You are viewing an incomplete version of our website. Please click to reload the website as full version.

IFNG antibody (Interferon gamma)

Details for Product anti-IFNG Antibody No. ABIN966336, Supplier: Log in to see
Antigen
  • IFG
  • Ifg
  • IFI
  • IFN-G
  • IFN-g
  • IFN-gamma
  • IFNG
  • IFNG2
Alternatives
anti-Human IFNG antibody for Enzyme Immunoassay
Reactivity
Human
719
267
145
68
38
36
35
29
26
21
20
14
14
12
12
11
10
9
9
6
6
6
6
6
5
2
1
1
1
Host
677
390
182
30
8
7
4
3
1
Clonality
Monoclonal
Conjugate
This IFNG antibody is un-conjugated
159
119
72
52
34
20
19
15
13
11
11
10
10
9
7
7
7
7
7
6
5
5
5
4
4
4
4
4
3
3
3
3
3
2
2
1
1
1
Application
ELISA, Western Blotting (WB)
733
654
445
129
122
119
70
60
55
54
50
38
35
25
24
14
13
9
8
7
6
5
4
4
4
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Isotype IgG1
Specificity Ni-NTA purified recombinant human IFN-gamma expressed in E. Coli strain BL21 (DE3)
Purification Antibodies are purified by protein A affinity chromatography
Alternative Name IFN-Y (IFNG Antibody Abstract)
Background Interferon-gamma (IFN-gamma) is a pro-inflammatory cytokine that is central in host resistance to infection. It is mainly produced by natural killer cells and CD4+ and CD8+ T cells, its receptors are found on nearly all cells, where it activates diverse responses that enable potential host cells to prevent invasive infection by bacteria, parasites and viruses. Takayanagi et al. (2000) demonstrated that IFN-gamma strongly suppresses osteoclastogenesis by interfering with the RANKL (602642)-RANK (603499) signaling pathway. Tsubota et al. (1999) reported that this upregulation in Sjogren syndrome patients may be controlled by interferon-gamma through the activation of transcription factor NFKB.
Gene ID 3458
Pathways Interferon-gamma Pathway
Application Notes Dilution: Western Blot: 1:500-1,000
ELISA: Determining optimal working dilutions by titration test.
Restrictions For Research Use only
Storage -20 °C
Background publications Takayanagi, Ogasawara, Hida, Chiba, Murata, Sato, Takaoka, Yokochi, Oda, Tanaka, Nakamura, Taniguchi: "T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma." in: Nature, Vol. 408, Issue 6812, pp. 600-5, 2000 (PubMed).

Product cited in: Tsubota, Fukagawa, Fujihara, Shimmura, Saito, Saito, Takeuchi: "Regulation of human leukocyte antigen expression in human conjunctival epithelium." in: Investigative ophthalmology & visual science, Vol. 40, Issue 1, pp. 28-34, 1999 (PubMed).